Interestingly, whereas sPD-L1 and sTIM-1 levels had decreased after the patients had recovered, the level of sMMP-7, a molecule that is a better biomarker, was still high 8 months post-COVID-19. The gene discussed is SPDL1; the disease is COVID-19.